Changes

no edit summary
Line 22: Line 22:  
|-
 
|-
 
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)|| ||
 
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)|| ||
|
+
|NEW
|
+
|NEW
 
|-
 
|-
 
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR|| ||
 
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR|| ||
|
+
|NEW
|
+
|NEW
 
|-
 
|-
 
|Chronic myeloid leukaemia||Disease||Jack Reid, MD (University of California, Irvine)  Mark Evans, MD (University of California, Irvine)  Fabiola Quintero-Rivera, MD (University of California, Irvine)|| || || || ||FQR|| ||
 
|Chronic myeloid leukaemia||Disease||Jack Reid, MD (University of California, Irvine)  Mark Evans, MD (University of California, Irvine)  Fabiola Quintero-Rivera, MD (University of California, Irvine)|| || || || ||FQR|| ||